NCT01173471 - A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Raised Intraocular Pressure

Interventions

DRUG

AZD4017

tablet, oral, one tablet once daily, 28 days

DRUG

Placebo

matching placebo tablet, oral, one tablet once daily, 28 days

DRUG

AZD4017

tablet, oral 2 tablets twice daily, 28 days

DRUG

Placebo

matching placebo tablets, oral, 2 tablets twice daily, 28 days

Trial Locations (11)

Research Site, Newport Beach

Research Site, Atlanta

Research Site, Morrow

Research Site, Overland Park

Research Site, Charlotte

Research Site, Durham

Research Site, Memphis

Research Site, Lund

Research Site, Mölndal

Research Site, Stockholm

Research Site, Nottingham